Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

DarioHealth presents an integrated digital health platform aimed at the comprehensive management of chronic conditions over the long term, focusing on areas such as cardiometabolic health (including diabetes, hypertension, and weight), musculoskeletal issues, and mental health. By merging connected consumer devices with a user-friendly mobile application, real-time human coaching, and AI-enhanced behavior modification pathways, the platform adopts a “one platform, one coach, one experience” philosophy. This allows users to effectively track important health metrics like blood glucose levels, blood pressure, body weight, and also monitor their exercise routines, dietary choices, and emotional well-being. Users benefit from tailored interventions that adapt to their evolving health needs, ensuring a personalized journey toward better health. With a foundation built on clinical validation, the platform boasts reported outcomes such as marked improvements in A1c levels, reductions in blood pressure categories, and decreases in BMI, while also addressing pain relief and posture enhancement in musculoskeletal health, alongside alleviation of anxiety and depressive symptoms in mental health. Overall, DarioHealth provides a holistic approach to chronic condition management that empowers users to take charge of their health journey.

Description

Introducing a versatile API designed to seamlessly integrate with your diabetes management system, offering tailored therapeutic education and enhanced insights into blood glucose level fluctuations. This solution enables real-time risk predictions, fostering greater personalization and improved system regulation, while adeptly managing complex living scenarios characterized by rapid glucose variations. With advancements in telemedicine and retrospective analysis, patients receive robust decision-support tools. Currently, Hillo is developing the next iterations of its AI technology, which includes a therapeutic recommendation system aimed at preventing hypoglycemia and hyperglycemia, anticipated to achieve CE mark class IIB by 2020. Additionally, a new generation of the artificial pancreas is projected for release in 2021, addressing key limitations of existing systems through ultra-personalization driven by machine learning. This innovative approach marks the introduction of the first self-learning artificial intelligence capable of predicting blood glucose levels, aiming to secure a CE mark as a medical device, thereby transforming diabetes management for users. In essence, Hillo's advancements could significantly enhance the quality of life for individuals managing diabetes.

API Access

Has API

API Access

Has API

Screenshots View All

Screenshots View All

Integrations

No details available.

Integrations

No details available.

Pricing Details

Free
Free Trial
Free Version

Pricing Details

No price information available.
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

DarioHealth

Country

United States

Website

www.dariohealth.com

Vendor Details

Company Name

Hillo

Country

France

Website

www.hillo.ai/

Product Features

Product Features

Alternatives

Alternatives

urNotes Reviews

urNotes

Micro Applications, Inc.
Altis Labs Nota Reviews

Altis Labs Nota

Altis Labs